Fallopian tube carcinosarcoma
Clinical trials for Fallopian tube carcinosarcoma explained in plain language.
Never miss a new study
Get alerted when new Fallopian tube carcinosarcoma trials appear
Sign up with your email to follow new studies for Fallopian tube carcinosarcoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo shows promise in ovarian cancer fight
Disease control OngoingThis study tests a new treatment for ovarian cancer that has returned after initial therapy. It combines a personalized vaccine made from a patient's own white blood cells (FRαDC) with an immunotherapy drug (pembrolizumab) to help the immune system attack cancer cells. The trial …
Matched conditions: FALLOPIAN TUBE CARCINOSARCOMA
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo aims to outsmart Chemo-Resistant ovarian cancer
Disease control OngoingThis early-phase trial tests a new drug called peposertib combined with a standard chemotherapy (PLD) in people with ovarian or related cancers that have stopped responding to platinum-based treatment. The main goal is to find the safest dose and understand side effects. About 54…
Matched conditions: FALLOPIAN TUBE CARCINOSARCOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC